PCGF2 and gastric cancer: We examined drug sensitivity by CCK-8 assay and found that Mel-18 overexpression sensitized gastric cancer cells to chemotherapy regent epirubicin (EPI) (Figure 2A) and irinotecan IRI (Figure 2B), suggesting Mel-18 negatively regulates chemo-drug resistance.